Sam Altman's $1.2 Billion Bet on Reversing Aging with AI
With a hefty investment in Retro Biosciences, Sam Altman, CEO of OpenAI, is pioneering the fight against aging with art…
Tag
Deep-dive articles with this tag.
With a hefty investment in Retro Biosciences, Sam Altman, CEO of OpenAI, is pioneering the fight against aging with art…